Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Am J Emerg Med ; 38(12): 2552-2556, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-31889577

RESUMEN

AIM: Carbon monoxide (CO) is a colorless, odorless gas and tasteless. CO poisoning (COP) is one of the most frequently encountered inhalation poisonings. The most common cause of morbidity in COP is delayed neurological sequelae (DNS). DNS is the occurrence of neuropsychiatric findings within 2-240 days after discharge of patients with COP and there are no definitive diagnostic criteria. The aim of our study is; to determine the risk factors and incidence of DNS. METHOD: Our study is a retrospective, observational study. Patients with the diagnosis of COP in the emergency department between 2015 and 2016 were included in the study. Patients age, gender, findings in the initial physical examination (PE) and neurological examination (NE), blood carboxyhemoglobin (COHb) level, relation between hyperbaric oxygen (HBO) treatment and DNS were assessed. RESULTS: Total of 72 patients were included in the study. Mean age was 33.43 ±â€¯20.89. It was determined that pathological findings in the initial NE are a significant predictive factor for DNS (Odds ratio 18.600, p:0.004). Significant relation between NE and HBO treatment was present (p:00.1). There was no statistically significant relationship between initial COHb level and receiving HBO treatment (p:0.9). Median COHb level of patients with DNS was 30 (min:10, max: 43), median COHb level of patients without DNS was 25 (min:10, max:44) and there was no statistically significant relationship between the two groups according to COHb levels (p:0.7). CONCLUSION: Pathological findings in the initial neurological examination had a predictive value for delayed neurological sequelae in patients with carbon monoxide poisoning.


Asunto(s)
Intoxicación por Monóxido de Carbono/fisiopatología , Carboxihemoglobina/metabolismo , Enfermedades del Sistema Nervioso/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Atención , Intoxicación por Monóxido de Carbono/metabolismo , Intoxicación por Monóxido de Carbono/psicología , Intoxicación por Monóxido de Carbono/terapia , Niño , Preescolar , Disfunción Cognitiva/epidemiología , Disfunción Cognitiva/etiología , Disfunción Cognitiva/fisiopatología , Disfunción Cognitiva/psicología , Confusión/epidemiología , Confusión/etiología , Confusión/fisiopatología , Confusión/psicología , Femenino , Hospitalización , Humanos , Oxigenoterapia Hiperbárica/estadística & datos numéricos , Hiperfagia/epidemiología , Hiperfagia/etiología , Hiperfagia/fisiopatología , Hiperfagia/psicología , Lactante , Tiempo de Internación , Masculino , Trastornos de la Memoria/epidemiología , Trastornos de la Memoria/etiología , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/psicología , Persona de Mediana Edad , Rigidez Muscular/epidemiología , Rigidez Muscular/etiología , Rigidez Muscular/fisiopatología , Rigidez Muscular/psicología , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Sistema Nervioso/fisiopatología , Enfermedades del Sistema Nervioso/psicología , Examen Neurológico , Examen Físico , Equilibrio Postural , Factores de Riesgo , Trastornos de la Sensación/epidemiología , Trastornos de la Sensación/etiología , Trastornos de la Sensación/fisiopatología , Trastornos de la Sensación/psicología , Factores de Tiempo
2.
CNS Drugs ; 32(9): 863-871, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-30014315

RESUMEN

OBJECTIVE: Psychotropic medications (e.g., antidepressants, anxiolytics, and neuroleptics) are increasingly prescribed with two or more taken concurrently (polypharmacy), and have been associated with an increased risk of falling. The aim of this study was to examine the association between psychotropic medication use and balance impairment using an objective balance measure. METHODS: We derived data from participants aged 40 years and older in the US National Health and Nutrition Examination Survey (1999/00-2003/04) who completed the Modified Clinical Trial of Sensory Interaction and Balance and indicated current medications (n = 3090). Balance impairment was defined as failing the Modified Clinical Trial of Sensory Interaction and Balance condition 4 (standing on foam surface, eyes closed). Medication use included specific psychotropic classes, a count of psychotropic medications, and a count of non-psychotropic medications taken concurrently. Nested multiple logistic regression assessed relationships between medication use and balance impairment, adjusting for covariates and complex sampling. RESULTS: One third of participants had balance impairment. After accounting for medical comorbidities, there was no relationship between individual classes of psychotropic medications and balance impairment. After adjusting for all covariates, there was a dose-response relationship between the number of psychotropic medications taken and balance impairment, with every additional medication associated with a 35% higher odds (odds ratio = 1.35; 95% confidence interval 1.07-1.70). In comparison, there was no increase in the odds of balance impairment associated with each additional medication taken for participants only taking non-psychotropic medications. CONCLUSIONS: Psychotropic medication polypharmacy is associated with an increased odds of balance impairment. Clinicians should exercise caution when prescribing combinations of psychotropic medications, and refer to physical therapy for assessment and treatment if balance impairment is detected.


Asunto(s)
Encuestas Nutricionales , Trastornos Psicóticos/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Trastornos de la Sensación/inducido químicamente , Trastornos de la Sensación/epidemiología , Adulto , Factores de Edad , Índice de Masa Corporal , Demografía , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Polifarmacia , Trastornos Psicóticos/epidemiología , Trastornos de la Sensación/diagnóstico , Factores Sexuales , Estados Unidos
3.
Hong Kong Med J ; 21(2): 165-71, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25722468

RESUMEN

Falls are a common problem in the elderly. A common error in their management is that injury from the fall is treated, without finding its cause. Thus a proactive approach is important to screen for the likelihood of fall in the elderly. Fall assessment usually includes a focused history and a targeted examination. Timed up-and-go test can be performed quickly and is able to predict the likelihood of fall. Evidence-based fall prevention interventions include multi-component group or home-based exercises, participation in Tai Chi, environmental modifications, medication review, management of foot and footwear problems, vitamin D supplementation, and management of cardiovascular problems. If possible, these are best implemented in the form of multifactorial intervention. Bone health enhancement for residential care home residents and appropriate community patients, and prescription of hip protectors for residential care home residents are also recommended. Multifactorial intervention may also be useful in a hospital and residential care home setting. Use of physical restraints is not recommended for fall prevention.


Asunto(s)
Accidentes por Caídas/prevención & control , Envejecimiento/fisiología , Ejercicio Físico/fisiología , Prevención Primaria/organización & administración , Anciano , Anciano de 80 o más Años , Densidad Ósea , Ambiente , Medicina Basada en la Evidencia , Femenino , Evaluación Geriátrica/métodos , Hong Kong/epidemiología , Humanos , Estilo de Vida , Masculino , Equilibrio Postural/fisiología , Pronóstico , Medición de Riesgo , Trastornos de la Sensación/epidemiología , Trastornos de la Sensación/prevención & control , Investigación Biomédica Traslacional , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/prevención & control
4.
Environ Int ; 68: 25-32, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24685489

RESUMEN

Methylmercury (MeHg) is a major environmental neurotoxicant that causes damage to the central nervous system. In Japan, industrial emission of MeHg has resulted in MeHg intoxication in Minamata and Niigata, the so-called Minamata disease. Humans are exposed to MeHg derived from natural sources, primarily fish and fish predators. Therefore, MeHg continues to be an environmental risk to human health, particularly in susceptible populations that frequently consume substantial amounts of fish or fish predators such as whale. This study aimed to investigate the health effects of MeHg exposure in adults. The subjects were 194 residents (117 males, 77 females; age 20-85 years) who resided in the coastal town of Taiji, the birthplace of traditional whaling in Japan. We analyzed hair for mercury content and performed detailed neurological examinations and dietary surveys. Audiometry, magnetic resonance imaging, and electromyography were performed to diagnose neurological defects. Whole blood mercury and selenium (Se) levels were measured in 23 subjects. The geometric mean of the hair mercury levels was 14.9 µg/g. Twelve subjects revealed hair mercury levels >50 µg/g (NOAEL) set by WHO. Hair mercury levels significantly correlated with daily whale meat intake. These results suggested that residents in Taiji were highly exposed to MeHg by ingesting MeHg-contaminated whale meat. Multivariate regression analysis demonstrated no significant correlations between hair mercury levels and neurological outcomes, whereas some of the findings significantly correlated with age. A significantly positive correlation between whole blood mercury and Se levels was observed and the whole blood mercury/Se molar ratios of all subjects were <1. These findings suggested that sufficient Se intake might be one of causes of the absence of adverse effects of MeHg exposure in this study.


Asunto(s)
Dieta , Contaminantes Ambientales/toxicidad , Carne/análisis , Compuestos de Metilmercurio/toxicidad , Sistema Nervioso/efectos de los fármacos , Adulto , Anciano , Anciano de 80 o más Años , Animales , Femenino , Contaminación de Alimentos/análisis , Cabello/química , Pérdida Auditiva Sensorineural/inducido químicamente , Pérdida Auditiva Sensorineural/epidemiología , Humanos , Japón/epidemiología , Masculino , Intoxicación del Sistema Nervioso por Mercurio/epidemiología , Compuestos de Metilmercurio/análisis , Persona de Mediana Edad , Selenio/sangre , Trastornos de la Sensación/inducido químicamente , Trastornos de la Sensación/epidemiología , Ballenas
5.
Osaka City Med J ; 60(2): 63-71, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25803881

RESUMEN

BACKGROUND: Studies have shown that children with pervasive developmental disorder (PDD) have high rates of sensory hypersensitivity. In addition, a few recent studies suggested that sensory hypersensitivity was related to anxiety or depression. However, most studies had methodological limitations because they included children with mental retardation and did not examine broadband psychopathology. Therefore, the purpose of this study was to examine the prevalence of sensory hypersensitivity in children with high-functioning PDD (HFPDD) and the correlation among sensory hypersensitivity, various characteristics, and broadband psychopathology. METHODS: We assessed 132 children with HFPDD (aged 6-15 years, 75% male) that were divided into sensory hypersensitivity (HS) and sensory non-hypersensitivity (non-HS) groups. A logistic regression model was used to examine correlations among sensory hypersensitivity, age, gender, PDD subtypes, socioeconomic status, and broadband psychopathology, including symptoms of anxiety and depression. RESULTS: Of the 132 children with HFPDD, 65.9% (n = 87) were categorized as HS and 34.1% (n = 45) as non-HS. The most common sensory hypersensitivity was auditory. Logistic regression analyses revealed that sensory hypersensitivity in HFPDD was significantly associated with autistic disorder and symptoms of anxiety and depression. CONCLUSIONS: Majority of children with HFPDD exhibited sensory hypersensitivity. Our findings suggested that sensory hypersensitivity may be a core feature of HFPDD and is possibly correlated to symptoms of anxiety and depression. We propose that sensory hypersensitivity in children with PDD should be aggressively assessed.


Asunto(s)
Trastornos Generalizados del Desarrollo Infantil/epidemiología , Trastornos de la Sensación/epidemiología , Umbral Sensorial , Estimulación Acústica , Adolescente , Factores de Edad , Ansiedad/epidemiología , Ansiedad/psicología , Umbral Auditivo , Estudios de Casos y Controles , Niño , Trastornos Generalizados del Desarrollo Infantil/diagnóstico , Trastornos Generalizados del Desarrollo Infantil/psicología , Depresión/epidemiología , Depresión/psicología , Femenino , Humanos , Japón/epidemiología , Modelos Logísticos , Masculino , Percepción Olfatoria , Estimulación Luminosa , Prevalencia , Factores de Riesgo , Trastornos de la Sensación/diagnóstico , Trastornos de la Sensación/psicología , Olfato , Gusto , Percepción del Gusto , Tacto , Percepción del Tacto , Percepción Visual
6.
Acta Oncol ; 51(8): 1036-44, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22676048

RESUMEN

BACKGROUND: Taxanes used in adjuvant therapy for breast cancer are neurotoxic, and thereby being a potential risk factor for persistent pain after breast cancer treatment (PPBCT) and sensory disturbances. The purpose was to compare patients treated with cyclophosphamide, epirubicin and fluorouracil (CEF) and cyclophosphamide and epirubicin + docetaxel (CE + T) in relation to PPBCT, sensory disturbances, peripheral sensory disturbances and functional impairment. MATERIAL AND METHODS: A comparative nationwide cross-sectional questionnaire study on two cohorts treated with CEF respectively CE + T, based on the Danish Breast Cancer Cooperative Groups database. INCLUSION CRITERIA: women treated with chemotherapy as adjuvant treatment for primary breast cancer, age 18-69 years, without recurrence. RESULTS: One thousand two hundred and forty-one patients allocated to CEF in 2005-2006 and 1652 patients allocated to CE + T in 2007-2008 were included. Six hundred and sixty-four (53%) with CEF and 861 (53%) patients with CE + T reported pain. In the multivariate analysis including available risk factors, CE + T did not confer an increased risk of PPBCT, OR 0.95 (95% CI 0.81-1.11), p = 0.52, compared to CEF. Patients treated with CE + T had a lower risk of sensory disturbances in the area of surgery compared with CEF, OR 0.75 (95% CI 0.62-0.90), p = 0.002. More CE + T patients reported peripheral sensory disturbances in the hands, OR 1.56 (95%CI 1.27-1.92), p < 0.0001, and in the feet, OR 2.0 (95% CI 1.66-2.42) p < 0.0001, compared to CEF. There was no difference in functional impairment (p = 0.62). CONCLUSION: Docetaxcel as adjuvant treatment for breast cancer does not increase the risk of PPBCT, sensory disturbances in the surgical area or functional impairment, but increase risk for peripheral sensory disturbances.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , Mastectomía , Neuralgia/inducido químicamente , Trastornos de la Sensación/inducido químicamente , Adulto , Anciano , Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/cirugía , Quimioterapia Adyuvante , Estudios Transversales , Ciclofosfamida/administración & dosificación , Ciclofosfamida/efectos adversos , Dinamarca/epidemiología , Docetaxel , Epirrubicina/administración & dosificación , Epirrubicina/efectos adversos , Femenino , Fluorouracilo/administración & dosificación , Fluorouracilo/efectos adversos , Pie/fisiopatología , Mano/fisiopatología , Humanos , Escisión del Ganglio Linfático , Mastectomía/métodos , Persona de Mediana Edad , Análisis Multivariante , Neuralgia/epidemiología , Dimensión del Dolor , Prevalencia , Estudios Prospectivos , Radioterapia/efectos adversos , Factores de Riesgo , Trastornos de la Sensación/epidemiología , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Taxoides/administración & dosificación , Taxoides/efectos adversos
7.
J Pediatr Surg ; 46(12): 2313-5, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22152872

RESUMEN

BACKGROUND: Laparoscopic anorectoplasty was introduced in 2000, but the procedure has not yet gained universal acceptance. Previous studies, including ours, reported satisfactory early postoperative outcome as compared with posterior sagittal anorectoplasty (PSARP), but mid- to long-term results are not available. Here, we aim to evaluate the mid- to long-term defecative function in these patients. MATERIALS AND METHODS: A retrospective study was carried out and included all patients who underwent laparoscopic-assisted anorectoplasty for high-/intermediate-type imperforate anus between 2001 and 2005. Their degree of continence was graded according to the Krickenbeck classification and compared with historical controls treated with PSARP. The results were compared using χ(2) test, and P < .05 was considered statistically significant. RESULTS: There were 18 patients who underwent laparoscopic anorectoplasty (LAR) in the study period. They were compared with 20 historical PSARP patients. For defecation sensation, 16 of the 18 LAR patients were positive, whereas there were 16 of 20 PSARP patients. Eight LAR patients were clean without any fecal soiling or incontinence (11/20 PSARP). Only 3 of 18 LAR had constipation as compared with 7 of 20 PSARP. The need for rectal enema for evacuation was seen in 1 of 20 LAR patients and 2 of 20 PSARP patients (for all categories, P > .05). CONCLUSIONS: Mid- to long-term follow-up study revealed satisfactory defecative function for patients with high-/intermediate-type imperforate anus after LAR. The outcome is at least as good as PSARP. Longer term follow-up with larger sample size is necessary to demonstrate the benefits of LAR over PSARP.


Asunto(s)
Canal Anal/cirugía , Ano Imperforado/cirugía , Defecación , Laparoscopía/métodos , Recto/cirugía , Preescolar , Estreñimiento/epidemiología , Estreñimiento/etiología , Enema , Incontinencia Fecal/epidemiología , Incontinencia Fecal/etiología , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Trastornos de la Sensación/epidemiología , Trastornos de la Sensación/etiología , Resultado del Tratamiento
8.
J Psychol ; 142(6): 601-13, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19049239

RESUMEN

Comorbidity between balance and anxiety disorders has been documented in clinical psychiatric and neurological samples. The authors aimed to determine whether the comorbidity of balance and anxiety disorders has an analogous representation in the normal population. Participants were 20 undergraduate students ages 22-29 years. The authors assigned them to high or low trait anxiety groups and performed a balance task in 3 experimental stages: baseline, training, and test. The baseline and test stages consisted of 4 wobbly and 4 stable trials each. The authors measured state anxiety in the form of auditory startle responses (ASRs) during the stable trials. In the baseline stage, the ASR amplitudes were higher in the high trait anxiety participants. In the test stage, the low trait anxiety participants performed the balance task better than the high trait anxiety participants did. These data suggest that the clinical entity designated as a comorbidity of balance and anxiety disorders has an analogous representation in the normal population.


Asunto(s)
Trastornos de Ansiedad/epidemiología , Equilibrio Postural , Trastornos de la Sensación/epidemiología , Estimulación Acústica , Adulto , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/psicología , Nivel de Alerta , Comorbilidad , Femenino , Habituación Psicofisiológica , Humanos , Masculino , Inventario de Personalidad , Valores de Referencia , Reflejo de Sobresalto , Trastornos de la Sensación/diagnóstico , Trastornos de la Sensación/psicología , Estudiantes/psicología , Adulto Joven
9.
Schizophr Res ; 92(1-3): 262-72, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17336502

RESUMEN

OBJECTIVE: Deficits in sensory gating are a common feature of schizophrenia. Failure of inhibitory gating mechanisms, shown by poor suppression of evoked responses to repeated auditory stimuli, has been previously studied using EEG methods. These methods yield information about the temporal characteristics of sensory gating deficits, but do not identify brain regions involved in the process. Hence, the neuroanatomical substrates of poor sensory gating in schizophrenia remain largely unknown. This study used functional magnetic resonance imaging (fMRI) to investigate the functional neuroanatomy of sensory gating deficits in schizophrenia. METHODS: Twelve patients with schizophrenia and 12 healthy comparison subjects were scanned at 3 Tesla while performing a sensory gating task developed for fMRI. P50 EEG evoked potential recordings from a paired-stimulus conditioning-test paradigm were obtained from the same subjects. RESULTS: Compared to healthy comparison subjects, patients with schizophrenia exhibited greater activation in the hippocampus, thalamus, and dorsolateral prefrontal cortex (DLPFC) during the fMRI sensory gating task. No group difference was observed in the superior temporal gyrus. Schizophrenia subjects also showed decreased P50 suppression as measured with EEG. Hemodynamic response in the fMRI measure was positively correlated with test/conditioning ratios from the EEG sensory gating measure. CONCLUSIONS: Poor sensory gating in schizophrenia is associated with dysfunction of an apparent network of brain regions, including the hippocampus, thalamus and DLPFC. Greater activation of these regions is consistent with evidence for diminished inhibitory function in schizophrenia.


Asunto(s)
Hipocampo/irrigación sanguínea , Hipocampo/fisiopatología , Corteza Prefrontal/irrigación sanguínea , Corteza Prefrontal/fisiopatología , Esquizofrenia/epidemiología , Esquizofrenia/fisiopatología , Trastornos de la Sensación/epidemiología , Trastornos de la Sensación/fisiopatología , Tálamo/irrigación sanguínea , Tálamo/fisiopatología , Adulto , Corteza Auditiva/irrigación sanguínea , Corteza Auditiva/fisiopatología , Circulación Cerebrovascular/fisiología , Electroencefalografía , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino
10.
J Neurol Sci ; 127(1): 11-28, 1994 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-7699385

RESUMEN

An epidemic outbreak of peripheral neuropathy affected Cuba in 1992-93 resulting in 50,862 cases (national cumulative incidence rate (CIR) 461.4 per 100,000). Clinical forms included retrobulbar optic neuropathy, sensory and dysautonomic peripheral neuropathy, dorsolateral myeloneuropathy, sensorineural deafness, dysphonia and dysphagia, spastic paraparesis, and mixed forms. For epidemiological purposes, cases were classified as optic forms (CIR 242.39) or peripheral forms (CIR 219.25). Increased risk was found among smokers (odds ratio (OR) 4.9), those with history of missing meals (OR 4.7) resulting in lower intake of animal protein, fat, and foods that contain B-vitamins, combined drinking and smoking (OR 3.5), weight loss (OR 2.8), excessive sugar consumption (OR 2.7) and heavy drinking (OR 2.3). Optic neuropathy was characterized by decreased vision, bilateral and symmetric central or cecocentral scotomata, and loss of color vision due to selective lesion of the maculopapillary bundles. Peripheral neuropathy was a distal axonopathy lesion affecting predominantly large myelinated axons. Deafness produced selective high frequency (4-8 kHz) hearing loss. Myelopathy lesions combined dorsal column deficits and pyramidal involvement of lower limbs with spastic bladder. Clinical features were those of Strachan syndrome and beriberi. Intensive search for neurotoxic agents, in particular organophosphorus esters, chronic cyanide, and trichloroethylene intoxication, yielded negative results. Treatment of patients with B-group vitamins and folate produced rewarding results. Most patients improved significantly and less than 0.1% of them remained with sequelae; there were no fatal cases. Supplementation of multivitamins to the entire Cuban population resulted in curbing of the epidemic. Overt malnutrition was not present, but a deficit of micronutrients, in particular thiamine, cobalamine, folate and sulfur amino acids appears to have been a primary determinant of this epidemic.


Asunto(s)
Avitaminosis/epidemiología , Brotes de Enfermedades , Enfermedades del Nervio Óptico/epidemiología , Enfermedades del Sistema Nervioso Periférico/epidemiología , Adolescente , Adulto , Anciano , Avitaminosis/tratamiento farmacológico , Beriberi/epidemiología , Estudios de Casos y Controles , Niño , Cuba/epidemiología , Sordera/epidemiología , Femenino , Ácido Fólico/uso terapéutico , Alimentos/efectos adversos , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Trastornos Nutricionales/epidemiología , Enfermedades del Nervio Óptico/tratamiento farmacológico , Enfermedades del Nervio Óptico/etiología , Paraparesia Espástica Tropical/epidemiología , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/etiología , Política , Trastornos de la Sensación/epidemiología , Toxinas Biológicas/análisis , Oligoelementos/deficiencia , Complejo Vitamínico B/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA